4.5 Article

Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of Rehmannia glutinosa and Cornus officinalis Sieb drug pair extract

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2015.12.020

Keywords

UPLC-MS; Loganin; Morroniside; Catalpol; Acteoside; Chronic kidney disease; Rehmannia glutinosa; Cornus officinalis; Pharmacokinetic study

Funding

  1. National Basic Research Program of China (973 Program) [2011CB505300, 2011CB505303]
  2. Nature Science Foundation of China [81072996, 81102743]
  3. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization [ZDXM-1-10]
  4. Construction Project for Jiangsu Key Laboratory for High Technology of TCM Formulae Research [BM2010576]

Ask authors/readers for more resources

A sensitive and rapid method for determination of loganin, morroniside, catalpol and acteoside in rat plasma after oral administration of Rehmannia glutinosa Libosch and Cornus officinalis Sieb drug pair based on ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS). Chromatographic separation was achieved using an Acquity UPLC BEH C18 column (100 mm x 2.1 mm, 1.7 mu m) at a flow rate of 0.4 mL/min, using gradient mode containing 0.1% formic acid in water and acetonitrile were used as the mobile phase A and B. Loganin, morroniside, catalpol, acteoside and the internal standard (chloramphenicol) were detected by selected reaction monitoring in the negative ion mode with the mass transition of m/z 451.0 -> 179.0 (morroniside), m/z 435.0 -> 227.0 (loganin), m/z 407.1 -> 199.1 (catalpol), m/z 623.2 -> 161.0 (acteoside) and m/z 320.8 -> 151.9 (chloramphenicol), respectively. All calibration curves showed good linearity (r > 0.991). The precision was evaluated by intra-day and inter-day assays and the RSD% were all within 9.58%. The recovery ranged from 67.62 to 80.14%. The method was successfully applied to pharmacokinetic study of the analytes in normal and doxorubicin-induced chronic kidney disease rat plasma. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available